Zampilimab (UCB-7858) is a humanised monoclonal antibody targeting TGM2, which binds to and inhibits the cross-linking transamidase activity of TG2, and is used to improve renal fibrosis.
Purity:
95%
CAS Number:
[2098280-42-1]
Target:
Glutaminase
* VAT and and shipping costs not included. Errors and price changes excepted